PS Ratio: 11.73

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 11.73 is 22% below its estimated 4-year average of 15.13, near the low end of its estimated 4-year range (10.31–309.50).

As of 2026-10-06T12:50:37.310Z. 20.22% below its estimated 12-month average of 14.70.

AXSM PS Ratio Metrics

P/S vs. estimated history

At 11.73, P/S is below its estimated 4-year median — higher than 4% of readings in its estimated 4-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Axsome Therapeutics, Inc. (AXSM)?

The P/S ratio for AXSM stock is 11.73.

Is Axsome Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 11.73 is 22% below its estimated 4-year average of 15.13, near the low end of its estimated 4-year range (10.31–309.50).

What is the estimated TTM average P/S ratio for Axsome Therapeutics, Inc. (AXSM)?

The estimated TTM average P/S ratio for AXSM stock is 14.70.

What is the estimated 3Y average P/S ratio for Axsome Therapeutics, Inc. (AXSM)?

The estimated 3Y average P/S ratio for AXSM stock is 14.32.

Showing the most recent 260 of 1,042 data points. The chart above shows the full history.

Related Metrics